Sinovac Biotech Ltd.

SVA · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$1,270$4,278$11,609$1,041
Short-Term Investments$9,953$7,035$1,806$135
Receivables$451$609$952$253
Inventory$140$181$376$106
Other Curr. Assets$17$23$172$25
Total Curr. Assets$11,831$12,126$14,915$1,560
Property Plant & Equip (Net)$1,032$1,173$1,084$304
Goodwill$0$0$0$0
Intangibles$9$80$41$10
Long-Term Investments$684$661$656$7
Tax Assets$30$71$52$27
Other NC Assets$73$3$0-$7
Total NC Assets$1,827$1,988$1,833$341
Other Assets$0$0$0$0
Total Assets$13,658$14,115$16,748$1,901
Liabilities
Payables$17$20$59$31
Short-Term Debt$82$11$15$43
Tax Payable$41$257$1,302$42
Deferred Revenue$20$33$93$379
Other Curr. Liab.$987$1,587$1,626$363
Total Curr. Liab.$1,148$1,092$2,413$680
LT Debt$217$64$130$94
Deferred Rev, NC$6$4$5$4
Deferred Tax Liab, NC$264$242$324$3
Other NC Liab.$0$0$0$1
Total NC Liab.$487$310$459$102
Other Liabilities$0$0$0$0
Cap. Leases$45$59$123$89
Total Liabilities$1,635$1,402$2,872$781
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings$7,119$7,226$7,142$144
AOCI$1,050$1,155$1,645$70
Other Equity$541$541$541$532
Total Equity$8,709$8,921$9,327$746
Supplemental Information
Minority Interest$3,313$3,791$4,549$374
Total Liab. & Tot. Equity$13,658$14,115$16,748$1,901
Net Debt-$971-$4,203-$11,464-$905